Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Melanopsin-Mediated Post-Illumination Pupillary Response in Idiopathic Rapid Eye Movement (REM) Sleep Behavior Disorder and Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Metabolism of the antioxidant micronutrient ergothioneine as a plasma biomarker of cognitive resilience in older people with Alzheimer's disease amyloid pathology.

Free radical biology & medicine·2026
Same author

Indices of Arterial Stiffness and the Alzheimer's Disease Biomarker, p-tau217, in Non-Demented Midlife Women.

Pulse (Basel, Switzerland)·2026
Same author

Artificial intelligence-based retinal imaging for brain health assessment: a scoping review.

The Lancet. Digital health·2026
Same author

Plasma brain-derived p-Tau217 outperforms other p-Tau species in detecting abnormal brain amyloid in an Asian cohort of older people with cerebrovascular disease burden.

The journal of prevention of Alzheimer's disease·2026
Same author

Optical coherence tomography artefact burden predicts cognitive decline and incident dementia.

Frontiers in aging neuroscience·2026
Same journal

Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Human brain connectome profiles mediate the relationship between pathology burden and clinical phenotypes in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Kat5 cKO mouse replicates biological domain signatures associated with Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Associations of self-reported obstructive sleep apnea with cognition and dementia risk in cognitively unimpaired middle-aged adults.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Inflammation profiles in Alzheimer's disease relate to cognition and neurodegeneration.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Yuan Cai1,2,3, Joyce R Chong4, Mitchell Kim Peng Lai5,6

  • 1Division of Neurology, Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, Hong Kong.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
PubMed
概括
此摘要是机器生成的。

结合人口因素,认知得分和GFAP和AD-RAI等生物标志物的多生物标志物模型有效预测患有阿尔茨海默病风险的个体的认知衰退.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经学 神经学
  • 生物标志物研究 生物标志物研究
  • 阿尔茨海默氏症疾病的诊断方法

背景情况:

  • 在AD相似性缩指数 (AD-RAI) 显示作为一个神经退行生物标志物的承诺.
  • 新兴的NIA-AA标准包括炎症 (GFAP) 和血管 (WMH) 标志物以及传统的AD生物标志物.
  • 使用组合生物标志物预测早期认知衰退需要进一步调查.

研究的目的:

  • 评估个人和联合生物标志物对非痴呆症个体认知衰退的预测性表现.
  • 评估炎症和血管生物标志物与AD-RAI和其他标志物的有用性.

主要方法:

  • 招募了314名没有痴呆症的参与者 (新加坡记忆诊所),随访2年.
  • 收集了基线血生物标志物 (GFAP,NfL,p-tau181,Aβ42) 和MRI测量 (AD-RAI,海马体积,WMH).
  • 认知衰退定义为CDR-SB评分在2年内增加1分.

主要成果:

  • 77名参与者 (24.5%) 的认知能力下降.
  • 血GFAP (AUC:0.73) 和AD-RAI (AUC:0.72) 显示出显著的预测价值.
  • 一个包括人口统计,CDR-SB,血生物标志物 (GFAP,Aβ42),AD-RAI和WMH在内的综合模型实现了最高的预测性能 (AUC:0.83).

结论:

  • 综合人口统计数据,认知得分和生物标志物 (GFAP,Aβ42,AD-RAI,WMH) 的多生物标志物方法有效预测认知衰退.
  • 将共病理生物标志物与AD-RAI和血Aβ生物标志物结合起来,可以增强预测模型.
  • 需要在不同的队列中进一步验证以确认可通用性.